Serum lipid and apolipoprotein profiles in newborns and six-year-old children: The Tallinn Young Family Study

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 65, Issue 7, 2005, Pages 541-550

  Kurvinen, E ^a,b   Aasvee, K ^a,b   Zordania, R ^c   Jauhiainen, M ^d   Sundvall, J ^d  

^a Estonian Institute of Cardiology   (Estonia)

^b NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^c TALLINN CHILDREN S HOSPITAL   (Estonia)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Apolipoprotein E polymorphism; Apolipoproteins; Children; Lipids; Lipoprotein (a); Newborn; Tracking

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; LIPOPROTEIN;

ANALYSIS OF VARIANCE; APGAR SCORE; ARTICLE; BIRTH; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILY STUDY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LIFE; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEWBORN; NORMAL HUMAN; OBSERVATION; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

APOLIPOPROTEINS; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; LIPIDS; MALE; PEDIGREE; PHENOTYPE;

EID: 31544480106     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/0365510500208324     Document Type: Article

References (63)

1. Enos W, Holmes R, Beyer J. Coronary disease among United States soldiers killed in action in Korea. JAMA 1953;152:1090-3.
2. McNamara JJ, Molot MD, Stremple JF, Cutting RT. Coronary artery disease in combat casualties in Vietnam. JAMA 1971;216:1185-7.
3. Yla-Herttuala S. Biochemistry of the arterial wall in developing atherosclerosis. Ann NY Acad Sci 1991;623:40-59.
4. Freedman DS, Byers T, Sell K, Kuester S, Nevell E, Lee S. Tracking of serum cholesterol levels in a multiracial sample of preschool children. Pediatrics 1992;90:80-6.
5. Kallio MJT, Salmenpera L, Siimes MA, Perheentupa J, Miettinen TA. Tracking of serum cholesterol and lipoprotein levels from the first year of life. Pediatrics 1993;91:949-54.
6. Newman WP, Freedman DS, Voors AW, Gard PD, Srinivasan SR, Cresenta JL, et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa Heart Study. N Engl J Med 1986;314:138-44.
7. PDAY Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking: a preliminary report from the pathobiological determinants of atherosclerosis in youth (PDAY) research group. JAMA 1990;264:3018-24.
8. Klag MJ, Ford DE, Mead LA, HE J, Whelton PK, Liang K-Y, et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 1993;328:313-8.
9. Freedman DS, Shear CL, Srinivasan SR, Webber LS, Berenson GS. Tracking serum lipids and apolipoproteins in children over an 8-year period: the Bogalusa Heart Study. Prev Med 1985;14:203-16.
10. Lauer RM, Lee J, Clarke WR. Factors affecting the relationship between childhood and adult cholesterol levels. The Muscatine Study. Pediatrics 1988;82:309-18.
11. Stuhldreher WL, Orchard TJ, Donahue RP, Kuller LH, Gloninger MF, Drash AL. Cholesterol screening in childhood sixteen-year Beaver County Lipid Study experience. J Pediatr 1991;119:551-6.
12. Raitakari OT, Porkka KV, Viikari JS, Ronnemaa T, Akerblom HK. Clustering of risk factors for coronary heart disease in children and adolescents. The cardiovascular risk in young Finns study. Acta Paediatr 1994;83:936-40.
13. Laskarzeski P, Morrison J, deGroot I, Kelly K, Mellies MJ, Khoury P, et al. Lipid and lipoprotein tracking in 108 children over a four-year period. Pediatrics 1979;64:584-91.
14. Webber LS, Srinivasan SR, Wattingney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am J Epidemiol 1991;133:884-99.
15. Porkka KV, Viikari JS. Tracking of serum lipids in children: association with the absolute lipid level: the cardiovascular risk in young Finns study. J Clin Epidemiol 1995;48:221-8.
16. Srinivasan SR, Berenson GS. Childhood lipoprotein profiles and implications for adult coronary artery disease: the Bogalusa Heart Study. Am J Med Sci 1995;310:62-7.
17. Bao W, Srinivasan SR, Wattingney WA, Bao W, Berenson GS. Usefulness of chilhood low-density lipoprotein cholesterol level in predicting adult dyslipidemia and other cardiovascular risks. The Bogalusa Heart Study. Arch Intern Med 1996;156:1315-20.
18. Niclas TA, von Duvillard SP, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to dyslipidemia in adults: the Bogalusa Heart Study. Int J Sports Med 2002;Suppl 1:S39-43.
19. Sporik R, Johnstone JH, Cogsvell JJ. Longitudinal study of cholesterol values in 68 children from birth to 11 years of age. Arch Dis Child 1991;66:134-7.
20. Bastida S, Sanchez-Muniz FJ, Cuena R, Perea S, Aragones A. High density lipoprotein-cholesterol changes in children with high cholesterol levels at birth. Eur J Pediatr 2002;161:94-8.
21. Kostner GM, Avogaro P, Gazzolato G, Marth E, Bittolo-Bon G, Quinci GB. Lipoprotein (a) and the risk of myocardial infarction. Atherosclerosis 1981;38:51-61.
22. Dahlen GM, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Association of levels of lipoprotein (a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986;74:758-65.
23. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle-aged men. Br Med J 1990;301:1248-51.
24. Jauhiainen M, Koskinen P, Ehnholm C, Frick MH, Mänttäri M, Manninen V, et al. Lipoprotein (a) and coronary heart disease risk, a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991;89:59-67.
25. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein (a) and risk of future myocardial infarction. J Am Med Assoc 1993;270:2195-9.
26. Boerwinkle E, Leffert CC, Lin J, Lacner C, Chiesa G, Hobbs HH. Apolipoprotein (a) gene accounts for greater than 90% of the variation in plasma lipoprotein (a) concentrations. J Clin Invest 1992;90:52-60.
27. Czinner A, Bihari V-M, Gruber E. Racial (gipsy/white) difference in serum Lp(a) levels and its relation to familial risk for atherosclerosis. Atherosclerosis 1994;109:286.
28. Vella JC, Calmarza P, Goni M, Berzoza J. Lipoprotein(a) and other lipidic parameters in newborns from Burgos, Spain. Atherosclerosis 1997;134:384.
29. Weisgraber KH, Rall SC, Mahley RW. Human E apolipoprotein heterogeneity: cysteine-arginine interchanges in the amino acid sequence of the the apo E isoforms. J Biol Chem 1981;256:9077-83.
30. Srinivasan SR, Ehnholm C, Wattingly WA, Bao W, Berenson G. The relation of apolipoprotein E polymorphism to multiple cardiovascular risk in children; the Bogalusa Heart Study. Atherosclerosis 1996;123:33-42.
31. Kallio MJ, Salmenpera L, Siimes MA, Perheentupa J, Gylling H, Miettinen TA. The apolipoprotein E phenotype has a strong influence on tracking of serum cholesterol and lipoprotein levels in children: a follow-up study from birth to the age of 11 years. Pediatr Res 1998;43:381-5.
32. Aasvee K, Jauhiainen M, Kurvinen E, Jordania R, Sundvall J, Ehnholm C. Lipoprotein(a), apolipopotein A-I and B serum levels in young families from Tallinn, Estonia. Relationships with other cardiovascular risk factors and nationality. Scand J Clin Lab Invest 1999;59:179-90.
33. Aasvee K, Kurvinen E, Jordania R, Jauhiainen M, Sundvall J. Lipoprotein parameters in relation to other risk factors of atherosclerosis in adults and newborns: Tallinn Young Family Study. Scand J Clin Lab Invest 2004;64:245-54.
34. Food and Nutrition III: Manual of Tallinn Technical University. Tallinn: TTU Press; 1997. ISBN 9985-59-037-6.
35. Rastas M, Seppänen R, Khuts LR. Ruoka-aineden ravintoainesisä lto. Helsinki: Kansaneläkelaitos, 1990.
36. Kostner GM, Avogaro P, Bittolo Bon G, Cazzolato G, Quinci GB. Determination of high-density lipoproteins: screening methods compared. Clin Chem 1979;25:939-42.
37. Friedewald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
38. Sundvall J, Sulonen GTB, Hiltunen O, Kiuru J, Pursiainen M, Jauhiainen M. Comparison a new immunoturbidimetric assay of human serum lipoprotein (a) to the ELISA and the IRMA methods. Scand J Clin Lab Invest 1995;55:171-80.
39. Riepponen P, Marniemi J, Rautaoja T. Immunoturbidimetric determination of apolipoproteins A-I and B in serum. Scand J Clin Lab Invest 1987;47:739-44.
40. Havekes LM, De Knijff P, Beisiegel U, Havinga J, Smit M, Klasen E. A rapid micromethod for apolipoprotein E phenotyping directly in serum. J Lipid Res 1987;28:455-63.
41. MedCalc for Windows. Statistics for Biochemical Research. Copyright ©, Belgium: Frank Schoonjans, 1993-999.
42. Van Biervliet JP, Labeur C, Michiels G, Usher DS, Rosseneu M. Lipoprotein (a) profiles and evolution in newborns. Atherosclerosis 1991;86:173-81.
43. Wang XZ, Wilcken DE, Dudman NP. Early expression of the apolipoprotein (a) gene: relationships between infants and their parent serum apolipoprotein (a) levels. Pediatrics 1992;89:401-6.
44. Wang XL, Wilcken DE, Dudman NP. Neonatal apo A-I, apo B and apo(a) levels in dried blood spots in an Australian population. Pediatr Res 1990;28:496-501.
45. Levitsky L, Scanu AM, Gould S. Lipoprotein (a) levels in black and white children and adolescents with IDDM. Diabetes Care 1991;14:283-7.
46. Srinivasan SR, Dahlen GH, Jarpa RA, Webber LS, Berenson GS. Racial (black-white) differences in serum lipoprotein(a) distribution and its relation to parental myocardial infarction in children. Bogalusa Heart Study. Circulation 1991;84:160-7.
47. Bao W, Srinivasan SR, Berenson GS. Tracking of serum apolipoproteins A-I and B in children and young adults: the Bogalusa Heart Study. J Clin Epidemiol 1993;46:609-16.
48. Webber LS, Srinivasan SR, Voors AW, Berenson GS. Persistence of levels for risk factor variable during the first year of life. The Bogalusa Heart Study. J Chron Dis 1980;33:157-67.
49. Fosoati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produced hydrogen peroxide. Clin Chem 1982;28:2077-9.
50. Freedman DS, Byers T, Sell K, Kuester S, Nevell E, Lee S. Tracking of serum cholesterol levels in a multiracial sample of preschool children. Pediatrics 1992;90:80-6.
51. Sanchez-Bayle M, Gonzalez-Requejo A, Ruiz-Jarabo C, Asensio J, Boeza S, Vila S, et al. Serum lipids and apolipoproteins in Spanish children and adolescents: a 5-year follow-up. Acta Paediatr 1996;85:292-4.
52. Steinmetz A, Thiemann E, Czekelius P, Kaffarnik H. Polymorphism of apolipoprotein E influences levels of serum apolipoproteins E and B in the human neonate. Eur J Clin Invest 1989;19:390-4.
53. Cameron ME, Van Staveren WA, editors. Manual on methodology for food consumption studies. Oxford, UK: Oxford University Press, 1988.
54. Lehtimäki T, Moilanen T, Viikari J, Akerblom K, Ehnholm C, Rönnemaa T, et al. Apolipoprotein E phenotypes in Finnish youth: a cross-sectional and 6-year follow-up study. J Lipid Res 1990;31:487-95.
55. Eto M, Watanabe K, Ishii K. Reciprocal effects of apolipoprotein E alleles on plasma lipid levels in normolipidemic subjects. Clin Genet 1986;29:477-84.
56. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J 1987;113:433-40.
57. Weintraub MS, Eisenberg S, Breslow JL. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987;80:1571-7.
58. Herrmann W, Hanf S, Kaffarnik H, Motzny S, Reissner J, Steinmetz A. The influence of apolipoprotein E polymorphism on plasma concentrations of apolipoprotein B and A-I during the first year of life. Pediatrics 1994;93:296-302.
59. Lehtimäki T, Porkka K, Viikari J, Ehnholm C, Akerblom H, Nikkari T. Apolipoprotein E phenotypes and serum lipids in newborns and 3-year-old children: the cardiovascular risk in the Young Finns Study. Pediatrics 1994;94:489-93.
60. Routi T, Rönnemaa T, Salo P, Seppänen R, Marniemi J, Viikari J, et al. Effects of prospective, randomized cholesterol-lowering dietary intervention and lipoprotein E phenotype on serum lipoprotein (a) concentrations of infants aged 7-24 mo. Am J Clin Nutr 1996;63:386-91.
61. Srinivasan SR, Ehnholm C, Elkasabany A, Berenson G. Influence of apolipoprotein E polymorphism on serum lipids and lipoprotein changes from childhood to adulthood. The Bogalusa Heart Study. Atherosclerosis 1999;143:435-43.
62. Gueguen R, Visvikis S, Steinmetz J, Siest G, Boerwinkle E. Analysis of genotype effects and their interactions using the apolipoprotein E polymorphism and longitudinal data. Am J Hum Genet 1989;45:793.
63. Barker DJB, editor. Fetal and infant origins of adult disease. London: BMJ Publishing Group, 1992.